Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Bonnie Carol Minsky currently manages a focused patent portfolio within the Biotechnology & Pharmaceuticals technology area. The portfolio shows a highly concentrated prosecution strategy, as evidenced by the presence of only 1 pending office action. This 1 action is being handled by 1 examiner, MELLER, MICHAEL V, who is also identified as the busiest examiner for this entity with 1 pending case.
The prosecution footprint is limited to 1 distinct art unit and 1 distinct examiner. This indicates a very narrow scope of active examination at this time. For a practitioner, this means the entire active portfolio's progress depends on the specific tendencies of MELLER, MICHAEL V. The 1 pending office action represents the entirety of the current workload for this portfolio. Because there is only 1 distinct art unit involved, the applicant does not need to navigate multiple departmental standards or varying examination cultures within the patent office. This streamlined structure allows for a highly targeted response to the 1 pending office action currently on the docket.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MELLER, MICHAEL V | 1 | 47.4% | +28.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18445371 | ARTHROPOD REPELLENT AND PROCEDURES | MELLER, MICHAEL V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18445371 | ARTHROPOD REPELLENT AND PROCEDURES | MELLER, MICHAEL V | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18445371 | ARTHROPOD REPELLENT AND PROCEDURES | MELLER, MICHAEL V | 1655 | §101§102§103§112 | Final Rejection | — | Pending | Aug 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBonnie Carol Minsky has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Michael V Meller has the most, with 1 of Bonnie Carol Minsky's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.